Results 121 to 130 of about 2,377 (150)

Impact of Siponimod on Clinical and Radiological Parameters of Secondary Progressive Multiple Sclerosis: A Real-World Prospective Study. [PDF]

J Clin Neurol
Stavrogianni K, Kitsos DK, Giannopapas V, Stefanou MI, Christouli N, Smyrni V, Chasiotis AK, Akrivaki A, Dimitriadou E, Chondrogianni M, Tsivgoulis G, Giannopoulos S.   +11 more
europepmc   +1 more source

Economic value of anti-CD20 therapies in multiple sclerosis: a systematic review of cost-effectiveness studies. [PDF]

Ther Adv Neurol Disord
Heinemann J, Zirkel M, Schoeffski O, Dersch R, Wiendl H.   +4 more
europepmc   +1 more source

Clinical Pharmacogenetics: Results After Implementation of Preemptive Tests in Daily Routine. [PDF]

J Pers Med
Díaz-Villamarín X, Martínez-Pérez M, Nieto-Sánchez MT, Fernández-Varón E, Torres-García A, Blancas I, Cabeza-Barrera J, Morón R.   +7 more
europepmc   +1 more source

Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study. [PDF]

Ther Adv Neurol Disord
Lucchini M, Borriello G, Haggiag S, Nicoletti CG, Fantozzi R, Buscarinu MC, Ferrazzano G, Cortese A, Marinelli F, Monteleone F, Centonze D, Conte A, Ferraro E, Gasperini C, Marfia GA, Pozzilli C, Salvetti M, Barbuti E, Bellucci G, Bianco A, Carlomagno V, Cruciani A, De Giglio L, Dionisi C, Ianniello A, Malimpensa L, Nasello M, Nociti V, Prosperini L, Tortorella C, Mirabella M.   +30 more
europepmc   +1 more source

Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseases. [PDF]

Ther Adv Neurol Disord
Schraad M, Mäurer M, Salmen A, Ruck T, Uphaus T, Fleischer V, Luessi F, Protopapa M, Steffen F, Hanuscheck N, Pape K, Brummer T, Shin J, Korn T, Klotz L, Lünemann JD, Pawlitzki M, Weber MS, Bayas A, Wildemann B, Hartung HP, Then Bergh F, Warnke C, Zettl UK, Berthele A, Haghikia A, Linker R, Tumani H, Meuth SG, Hemmer B, Wiendl H, Kümpfel T, Gold R, Bittner S, Zipp F.   +34 more
europepmc   +1 more source

Diagnoses of Multiple Sclerosis and Related Disorders and Disease-Modifying Therapies: A Comparison of the Danish Multiple Sclerosis Registry With Other Danish Health Registries. [PDF]

Brain Behav
Joensen H, Framke E, Pontieri L, Magyari M.   +3 more
europepmc   +1 more source

Nucleoside-Analog Reverse-Transcriptase Inhibitors (NRTIs) Against Multiple Sclerosis: Comprehensive Review on a Possible Novel Therapeutic Approach. [PDF]

Neurol Int
Martinisi A, Paganetti P.
europepmc   +1 more source

Structural basis of allosteric and bitopic ligands binding in sphingosine-1-phosphate receptors 2 and 3. [PDF]

Protein Cell
Wu Y, Chen Q, Wang H, Liu K, Wei J, Wang M, Chen K, Zhu Y, Han S, Yi C, Ma L, Schnapp G, Pautsch A, Gnamm C, Grauert M, Schmidt E, Tan Q, Wu B, Zhao Q.   +18 more
europepmc   +1 more source

Intracerebral Hemorrhage Induces Monocyte TNF Signaling in Patients That Is Suppressed by BAF312. [PDF]

Ann Clin Transl Neurol
DeLong JH, Díaz-Pérez S, Sheth KN, Cha JH, Malanga CJ, Wagner PGM, Pezous N, Hanin A, Walsh KB, Hinson HE, Sansing LH.   +10 more
europepmc   +1 more source